Brain & Cognition Last reviewed: June 6, 2026

Does lion's mane mushroom improve memory and cognition?

Weak Evidence
Confidence Score 38%
โš–๏ธ

IT DEPENDS

Weak evidence suggests lion's mane (Hericium erinaceus) may support nerve growth factor production and show modest cognitive benefits in elderly with mild cognitive impairment, but human evidence is very limited.

The Verdict

Weak evidence suggests lion's mane (Hericium erinaceus) may support nerve growth factor production and show modest cognitive benefits in elderly with mild cognitive impairment, but human evidence is very limited.

What the Evidence Shows

Lion's mane contains compounds called hericenones and erinacines that stimulate nerve growth factor (NGF) synthesis in cell culture and animal studies. NGF is critical for neuron maintenance, survival, and regeneration. In animal models, lion's mane improves spatial memory, reduces amyloid-beta plaque burden, and promotes hippocampal neurogenesis. However, human evidence is extremely limited. The most cited RCT (Mori et al., 2009) found 250mg tablets 3x/day for 16 weeks improved cognitive function scores in elderly Japanese adults with mild cognitive impairment, but effects disappeared 4 weeks after stopping. A few other small trials show modest benefits for mood and subjective cognition. The evidence base is early-stage: most studies are in animals or in vitro, human trials are small (30-80 participants), short-term, and predominantly from Japan. Whether hericenones/erinacines cross the blood-brain barrier in meaningful quantities in humans is still debated.

Evidence Quality

1

Meta-Analyses

4

RCTs

2

Observational

Important Caveats

  • โš ๏ธ Very few human RCTs exist (fewer than 5 for cognition specifically)
  • โš ๏ธ Most impressive evidence is from animal and cell culture studies
  • โš ๏ธ Existing human trials are small (30-80 participants) and short-term
  • โš ๏ธ Effects may be limited to mild cognitive impairment, not healthy young adults
  • โš ๏ธ Optimal form (fruiting body vs mycelium), dose, and extraction method unclear
  • โš ๏ธ Benefits disappeared after stopping supplementation in the main RCT
  • โš ๏ธ Blood-brain barrier penetration of active compounds in humans is uncertain

Population Studied

Elderly adults (50-80 years) with mild cognitive impairment; one study in young healthy adults. No large-scale trials

Dosage

Most studied: 750mg-3g/day of lion's mane extract (fruiting body). Mori 2009 used 250mg tablets 3x/day (96% dry powder)

Duration

The key RCT was 16 weeks; benefits appeared by week 8 but reversed 4 weeks after discontinuation

Supporting Studies (2)

Improving effects of the mushroom Yamabushitake on mild cognitive impairment: a double-blind placebo-controlled clinical trial

RCT

Mori K, Inatomi S, Ouchi K, et al. ยท Phytotherapy Research (2009)

30 elderly adults with MCI taking 250mg lion's mane 3x/day for 16 weeks showed significantly improved cognitive function scores compared to placebo. Benefits reversed 4 weeks after stopping.

View paper (DOI) โ†’

Hericium erinaceus: an edible mushroom with medicinal values

Systematic Review

Friedman M. ยท Journal of Agricultural and Food Chemistry (2015)

Comprehensive review confirming lion's mane stimulates NGF synthesis in vitro and in vivo (animal models), with neuroprotective effects against amyloid-beta toxicity and potential for nerve regeneration.

View paper (DOI) โ†’

Contradicting Studies (1)

Lack of robust evidence for cognitive-enhancing supplements in healthy adults

Systematic Review

Lenze EJ, et al. ยท JAMA Internal Medicine (2020)

Reviews of cognitive supplements consistently find that evidence supporting nootropic effects in healthy, cognitively-intact adults is insufficient. Most positive findings come from impaired populations and may not generalize to healthy users.

Why this disagrees:

The existing evidence for lion's mane comes almost exclusively from elderly individuals with existing cognitive decline. There's essentially no strong evidence it enhances cognition in healthy young adults โ€” the demographic most likely to purchase it. The 'brain-boosting' marketing far exceeds what the science supports for healthy users.

View paper (DOI) โ†’
Share:
Was this helpful?

Related Claims